Anti-HDAC2 monoclonal antibody

Pre-made anti-HDAC2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to HDAC2/HDAC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T51191-Ab-1/ GM-Tg-hg-T51191-Ab-2Anti-Human HDAC2 monoclonal antibodyHuman
GM-Tg-rg-T51191-Ab-1/ GM-Tg-rg-T51191-Ab-2Anti-Rat HDAC2 monoclonal antibodyRat
GM-Tg-mg-T51191-Ab-1/ GM-Tg-mg-T51191-Ab-2Anti-Mouse HDAC2 monoclonal antibodyMouse
GM-Tg-cynog-T51191-Ab-1/ GM-Tg-cynog-T51191-Ab-2Anti-Cynomolgus/ Rhesus macaque HDAC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T51191-Ab-1/ GM-Tg-felg-T51191-Ab-2Anti-Feline HDAC2 monoclonal antibodyFeline
GM-Tg-cang-T51191-Ab-1/ GM-Tg-cang-T51191-Ab-2Anti-Canine HDAC2 monoclonal antibodyCanine
GM-Tg-bovg-T51191-Ab-1/ GM-Tg-bovg-T51191-Ab-2Anti-Bovine HDAC2 monoclonal antibodyBovine
GM-Tg-equg-T51191-Ab-1/ GM-Tg-equg-T51191-Ab-2Anti-Equine HDAC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T51191-Ab-1/ GM-Tg-hg-T51191-Ab-2; GM-Tg-rg-T51191-Ab-1/ GM-Tg-rg-T51191-Ab-2;
GM-Tg-mg-T51191-Ab-1/ GM-Tg-mg-T51191-Ab-2; GM-Tg-cynog-T51191-Ab-1/ GM-Tg-cynog-T51191-Ab-2;
GM-Tg-felg-T51191-Ab-1/ GM-Tg-felg-T51191-Ab-2; GM-Tg-cang-T51191-Ab-1/ GM-Tg-cang-T51191-Ab-2;
GM-Tg-bovg-T51191-Ab-1/ GM-Tg-bovg-T51191-Ab-2; GM-Tg-equg-T51191-Ab-1/ GM-Tg-equg-T51191-Ab-2
Products NameAnti-HDAC2 monoclonal antibody
Formatmab
Target NameHDAC2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-HDAC2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T51191-Ag-1Recombinant multi-species HDAC2/ HD2/ RPD3 protein


    Target information

    Target IDGM-T51191
    Target NameHDAC2
    Gene ID3066,15182,84577,694662,475035,101088165,407223,100072578
    Gene Symbol and SynonymsD10Wsu179e,HD2,HDAC2,KDAC2,mRPD3,RPD3,YAF1,Yy1bp
    Uniprot AccessionQ92769
    Uniprot Entry NameHDAC2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000196591
    Target ClassificationTumor-associated antigen (TAA)

    The target: HDAC2, gene name: HDAC2, also named as HD2, RPD3, YAF1. This gene product belongs to the histone deacetylase family. Histone deacetylases act via the formation of large multiprotein complexes, and are responsible for the deacetylation of lysine residues at the N-terminal regions of core histones (H2A, H2B, H3 and H4). This protein forms transcriptional repressor complexes by associating with many different proteins, including YY1, a mammalian zinc-finger transcription factor. Thus, it plays an important role in transcriptional regulation, cell cycle progression and developmental events. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.